NeueHealth, Inc. (NYSE:NEUE) CEO Sells $76,257.20 in Stock

NeueHealth, Inc. (NYSE:NEUEGet Free Report) CEO George Lawrence Mikan III sold 12,440 shares of the stock in a transaction that occurred on Friday, March 14th. The stock was sold at an average price of $6.13, for a total value of $76,257.20. Following the sale, the chief executive officer now directly owns 249,454 shares of the company’s stock, valued at approximately $1,529,153.02. The trade was a 4.75 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website.

George Lawrence Mikan III also recently made the following trade(s):

  • On Wednesday, March 12th, George Lawrence Mikan III sold 13,180 shares of NeueHealth stock. The stock was sold at an average price of $6.93, for a total value of $91,337.40.
  • On Monday, March 10th, George Lawrence Mikan III sold 1,604 shares of NeueHealth stock. The stock was sold at an average price of $7.06, for a total transaction of $11,324.24.
  • On Friday, March 7th, George Lawrence Mikan III sold 26,660 shares of NeueHealth stock. The shares were sold at an average price of $7.19, for a total value of $191,685.40.
  • On Monday, January 6th, George Lawrence Mikan III sold 31,798 shares of NeueHealth stock. The shares were sold at an average price of $7.33, for a total value of $233,079.34.
  • On Tuesday, December 17th, George Lawrence Mikan III sold 16,803 shares of NeueHealth stock. The shares were sold at an average price of $4.18, for a total value of $70,236.54.

NeueHealth Trading Up 9.4 %

NYSE NEUE opened at $5.10 on Wednesday. The company has a market cap of $42.25 million, a PE ratio of -0.10 and a beta of 0.56. NeueHealth, Inc. has a 12 month low of $3.79 and a 12 month high of $7.66. The stock has a 50 day moving average of $7.16 and a 200-day moving average of $6.01.

Institutional Investors Weigh In On NeueHealth

Hedge funds have recently added to or reduced their stakes in the business. Virtu Financial LLC acquired a new stake in NeueHealth during the 4th quarter valued at $76,000. Northern Trust Corp lifted its holdings in NeueHealth by 66.8% during the 4th quarter. Northern Trust Corp now owns 32,644 shares of the company’s stock valued at $242,000 after purchasing an additional 13,074 shares during the last quarter. Finally, Partners Group Holding AG acquired a new stake in NeueHealth during the 3rd quarter valued at $463,000. Institutional investors and hedge funds own 63.88% of the company’s stock.

Wall Street Analyst Weigh In

Separately, Royal Bank of Canada cut their price objective on NeueHealth from $8.00 to $7.00 and set a “sector perform” rating for the company in a report on Monday, December 9th.

View Our Latest Analysis on NEUE

NeueHealth Company Profile

(Get Free Report)

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.

Further Reading

Insider Buying and Selling by Quarter for NeueHealth (NYSE:NEUE)

Receive News & Ratings for NeueHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeueHealth and related companies with MarketBeat.com's FREE daily email newsletter.